iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Candidiasis (Invasive)

Candidiasis (Invasive)

Management of systemic Candida infections.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Infectious DiseasesCritical Care

Clinical Guidelines

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (IDSA)
National
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
National
An Italian consensus for invasive candidiasis management (ITALIC)
Local
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Local
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Local
ESCMID* guideline for the diagnosis and management of Candida diseases
Local

Recent iatroX Q&As

  • What are the key diagnostic criteria for invasive candidiasis in immunocompromised patients?Updated: 8/22/2025
  • What are the potential complications of invasive candidiasis that I should monitor for in my patients?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play